Diagnostic Value of G and GM Tests in Acute Leukemia Patients with Invasive Fungal Disease.
10.19746/j.cnki.issn.1009-2137.2019.05.049
- Author:
Ke-Yu QIAN
1
,
2
;
Quan-Xing LYU
1
,
2
;
Li-Jun DAI
1
,
2
;
Hui-Rong CHANG
1
,
2
;
De-Pei WU
1
,
2
;
Ai-Ning SUN
1
,
3
Author Information
1. Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University
2. Key Laberatory of Thrombosis and Hemostasis, Ministry of Health, Suzhou 215006, Jiangsu Province, China.
3. Key Laberatory of Thrombosis and Hemostasis, Ministry of Health, Suzhou 215006, Jiangsu Province, China E-mail: sunaining@suda.edu.cn.
- Publication Type:Journal Article
- MeSH:
Humans;
Invasive Fungal Infections;
diagnosis;
etiology;
Leukemia, Myeloid, Acute;
complications;
Mannans
- From:
Journal of Experimental Hematology
2019;27(5):1678-1681
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the diagnostic value of (1, 3) -β-D-glucan and galactomannan (GM) tests in the patients with acute leukemia complicated by invasive fungal disease, and explore the application of serological detection (G/GM) and lung CT for early diagnosis of invasive fungal disease (IFD).
METHODS:A total of 493 patients with acute leukemia complicated by high risk invasive fungal infection, also receival G and GM tests, in Department of hematology of our hospital from June 2016 to December 2016 were selected and were divided into IFD-confirmed group (62 cases) including confirmed and clinical diagnesed IFD, and IFD-unconfirmed group (431 cases) including suspected IFD and non-IFD according to the diagnostic criteria of IFD. The results of G and GM tests in patients of 2 groups were analyzed, then the diagnostic efficacy of G and GM done and combination evaluated. In addition, 26 patients whose lung CT negative at hospitalization, moreover, presentation of changes in lung by CT during hospitalization and serological G and GM test positive were selected, and the difference of time between serological that postive and presentation of changes in lung by CT were compared for the estimation of early diagnotic value.
RESULTS:The positive rate of (1, 3) -β-D-glucan in IFD-confirmed group and IFD-unconfirmed group was 56.5% and 10.4%, respectively. Meanwhile, that of galactomannan test was 41.9% and 9.0%, respectively. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of (1, 3) -β-D-glucan was 56%, 90%, 44% and 92%, and that of galactomannan was 42%、91%、40% and 93%, respectively. Moreover, the combination of (1, 3) -β-D-glucan and galactomannan could raise the sensitivity to 69% and specificity to 98%. The positive results of serological detection (G/GM) come earlier about five days than CT changes.
CONCLUSION:Both (1, 3) -β-D-glucan and galactomannan test have high sensitivity and specificity, and the combination of them can improve the diagnostic efficacy, and make the clinical antifungal therapy more precisely. In the early clinical diagnosis of IFD, the positive results of serological detection coming earlier than lung CT.
